News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

PARI Partner Project News

Partner Project News

Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001

PARI Publication

PARI Publication

A Novel Human Factors Approach for a New Platform-Based, Breath-Triggered Nebuliser

Published

July 22, 2022

Category

Publications

Differential Performance and Lung Deposition of Levofloxacin with Different Nebulisers Used in Cystic Fibrosis.

Differential Performance and Lung Deposition of Levofloxacin with Different Nebulisers Used in Cystic Fibrosis.

Published

June 17, 2022

Category

Partner News

Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic

Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic

Published

April 25, 2022

Category

PARI Publications

Unsteady Aerosol Output Rate Measurements: Assessing the eFlow Nebulizer Aerosol Bolus.

Unsteady Aerosol Output Rate Measurements: Assessing the eFlow Nebulizer Aerosol Bolus.

Published

April 25, 2022

Category

PARI Publications

Towards More Realistic In Vitro Nebulizer Testing.

Towards More Realistic In Vitro Nebulizer Testing.

Published

April 21, 2022

Category

PARI Publications

Development of a Novel Test Stand for the Measurement of Valved Holding Chambers with Facemasks.

Development of a Novel Test Stand for the Measurement of Valved Holding Chambers with Facemasks.

Contact us

eFlow-partneringpari.com

Two smiling men in a blue circle. The central man wears glasses and a light blue shirt. The man on the left has a beard and a blue patterned shirt.

PARI Business Development Team